Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Denali Therapeutics Inc.

Biological Products, (No Diagnostic Substances) · South San Francisco, CA, United States

  1. PrincipalsRyan J. WattsPresident and CEOand 4 more
  2. CompanyDenali Therapeutics Inc.South San Francisco, CA, United States
  3. Phone line+1 (650) 866-8547General business
Request a quote

Denali Therapeutics Inc. is an SEC-registered Nasdaq-listed company (ticker DNLI) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 5

Chief executive

Ryan J. WattsPresident and CEO

Chair & board

Felix BakerDirector (Board)
Hauwermeiren Timothy VanDirector (Board)
Julian BakerDirector (Board)

Legal

Alexander O. SchuthCOFO and Secretary

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Ryan J. Watts — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Alexander O. Schuth — COFO and Secretary

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Hauwermeiren Timothy Van — Director (Board)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers